Skip to main content

      More Results
        More Results

        From Sectors and Smart Beta to Fixed Income, SPDR Exchange Traded Funds (ETFs) give you wide access to diverse investment opportunities. Find out more.

        Okay

        SPDR® MSCI World Health Care UCITS ETF WHEA LN

        Concentrated investments in a particular sector or industry tend to be more volatile than the overall market and increases risk that events negatively affecting such sectors or industries could reduce returns, potentially causing the value of the Fund’s shares to decrease. 

        Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

        ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

        Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

        Overview Performance Holdings Documents Purchase Information More Insights
        NAV USD (Official NAV)
        $61.36
        as of 22 Nov 2024
        Base Fund Currency
        USD
        1 Day Nav Change
        +$0,26 (+0,42%)
        as of 22 Nov 2024
        Assets Under Management
        $596.00 M
        as of 22 Nov 2024
        TER
        0.30%
        as of 31 Oct 2024
        Morningstar Medalist rating
        as of 30 Sep 2024

        Quick Links

        Fund Objective

        The investment objective of the Fund is to track the performance of companies in the Health Care sector, across developed markets globally.

        Index Description

        The MSCI World Health Care 35/20 Capped Index measures the performance of global equities that are classified as falling within the health care sector, as per the Global Industry Classification Standard (GICS).

        Fund Information as of 22 Nov 2024

        ISIN IE00BYTRRB94
        iNAV Ticker

        *These ticker codes are representative of the primary listing exchange.

                 		INWHEAE
        Inception Date 29 Apr 2016
        Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
        Base Fund Currency USD
        Income Treatment Accumulation
        Settlement Cycle Redemption Settlement Cycle, DD+3; Subscription Settlement Cycle, DD+2
        Trading Cycle DD+1
        TER 0.30%
        Benchmark MSCI World Health Care 35/20 Capped Index
        Minimum Investment 1 Share
        Trading Currency EUR, GBP, USD
        UCITS Compliant Yes
        Domicile Ireland
        Investment Manager State Street Global Advisors Europe Limited
        Sub-Investment Manager(s)

        State Street Global Advisors Limited
        Fund Umbrella SSGA SPDR ETFs Europe II plc
        Replication Method Replicated
        Distribution Frequency -
        PEA Eligible No
        ISA Eligible Yes
        SIPP Eligible Yes
        UK Reporting Status Yes
        Securities Lending Yes

        Listing and Ticker Information as of 22 Nov 2024

        Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
        Euronext Amsterdam (Primary) EUR 03 May 2016 WHEA BYZJ0B0 WHEA NA WHEA.AS
        London Stock Exchange USD 04 May 2016 WHEA BYYW128 WHEA LN WHEA.L
        SIX Swiss Exchange USD 06 May 2016 WHEA BYZJ0N2 WHEA SE WHEA.S
        Borsa Italiana EUR 30 Jan 2019 WHEA BHXH6F3 WHEA IM WHEA.MI
        London Stock Exchange GBP 04 Apr 2022 HEAW BNLYDJ1 HEAW LN HEAW.L
        Deutsche Börse EUR 20 Nov 2023 SPFS BYTRRB9 SPFS GY SPFS.DE

        INAV

        Estimated NAV per Unit at 4PM, Hong Kong as of
        Estimated NAV per Unit as of (Updated every 15 seconds)
        As of (Updated every 15 seconds)
        INAV TICKER CURRENCY INAV

        The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.

        Fund Characteristics as of 21 Nov 2024

        Average Market Cap (M) $211,665.50 M
        Number of Holdings 136
        Average Price/Book 4.34
        Price/Earnings Ratio FY1 19.91

        Index Characteristics as of 21 Nov 2024

        Index Dividend Yield

        This measures the weighted average of gross dividend Yield of stocks, in the index.

                 		1.71%

        Fund Market Price as of 22 Nov 2024

        Bid Price €56.50
        Offer Price €59.98
        Closing Price €59.02
        Bid/Offer Spread €3.48
        Day High €59.14
        Day Low €58.43
        52 Week High €62.08
        52 Week Low €50.13

        Fund Net Asset Value as of 22 Nov 2024

        NAV USD (Official NAV) $61.36
        NAV EUR €58.94
        NAV GBP £48.99
        Assets Under Management $596.00 M
        Shares in Issue 9,713,348
        Most Recent NAV/NAV History

        Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.

        Fund Performance

        • Fund Inception Date: 29 Apr 2016
        • Index Inception Date: 07 May 2020
        • Performance Inception Date: 28 Feb 2009

        as of 31 Oct 2024

        As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year 10 Year Since Inception
        28 Feb 2009
        Fund Net 31 Oct 2024 -4.83% -2.62% 8.54% 19.81% 3.22% 9.27% 8.02% 12.47%
        Difference 31 Oct 2024 -0.01% -0.03% -0.09% -0.13% -0.12% -0.17% -0.15% -0.20%
        Fund Gross 31 Oct 2024 -4.81% -2.55% 8.82% 20.17% 3.53% 9.60% 8.35% 12.85%
        Difference 31 Oct 2024 0.01% 0.04% 0.18% 0.23% 0.19% 0.16% 0.19% 0.18%
        Index
        MSCI World Health Care 35/20 Capped Index

        Index Change: “Index” reflects linked performance returns of both the MSCI World Health Care 35/20 Capped Index and the MSCI World Health Care Index. The index returns are reflective of the MSCI World Health Care Index from fund inception until November 30, 2020 and of MSCI World Health Care 35/20 Capped Index effective November 30, 2020 to present.

                 		31 Oct 2024 -4.82% -2.59% 8.63% 19.94% 3.35% 9.44% 8.16% 12.66%

        as of 31 Oct 2024

        As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year 10 Year Since Inception
        28 Feb 2009
        Fund Net 31 Oct 2024 -4.83% -2.62% 8.54% 19.81% 9.99% 55.79% 116.22% 530.59%
        Difference 31 Oct 2024 -0.01% -0.03% -0.09% -0.13% -0.39% -1.22% -2.99% -17.37%
        Fund Gross 31 Oct 2024 -4.81% -2.55% 8.82% 20.17% 10.98% 58.14% 123.08% 564.47%
        Difference 31 Oct 2024 0.01% 0.04% 0.18% 0.23% 0.60% 1.13% 3.87% 16.51%
        Index
        MSCI World Health Care 35/20 Capped Index

        Index Change: “Index” reflects linked performance returns of both the MSCI World Health Care 35/20 Capped Index and the MSCI World Health Care Index. The index returns are reflective of the MSCI World Health Care Index from fund inception until November 30, 2020 and of MSCI World Health Care 35/20 Capped Index effective November 30, 2020 to present.

                 		31 Oct 2024 -4.82% -2.59% 8.63% 19.94% 10.38% 57.01% 119.21% 547.96%

        as of 31 Oct 2024

        2024 (YTD) 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
        Fund Net 8.54% 3.63% -5.56% 19.59% 13.26% 23.34% 2.48% 19.69% -6.89% 6.17% 17.71%
        Difference -0.09% -0.12% -0.14% -0.22% -0.26% 0.09% -0.04% -0.11% -0.08% -0.43% -0.39%
        Fund Gross 8.82% 3.94% -5.27% 19.94% 13.60% 23.70% 2.78% 20.05% -6.58% 6.58% 18.15%
        Difference 0.18% 0.19% 0.14% 0.14% 0.08% 0.46% 0.27% 0.25% 0.23% -0.02% 0.05%
        Index
        MSCI World Health Care 35/20 Capped Index

        Index Change: “Index” reflects linked performance returns of both the MSCI World Health Care 35/20 Capped Index and the MSCI World Health Care Index. The index returns are reflective of the MSCI World Health Care Index from fund inception until November 30, 2020 and of MSCI World Health Care 35/20 Capped Index effective November 30, 2020 to present.

                 		8.63% 3.76% -5.41% 19.80% 13.52% 23.24% 2.51% 19.80% -6.81% 6.60% 18.10%

        Performance Gross and Net of All Fees.

        Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

        Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.

        Index Change: “Index” reflects linked performance returns of both the MSCI World Health Care 35/20 Capped Index and the MSCI World Health Care Index. The index returns are reflective of the MSCI World Health Care Index from fund inception until November 30, 2020 and of MSCI World Health Care 35/20 Capped Index effective November 30, 2020 to present.

        Deviation & Tracking Error as of 31 Oct 2024

        Standard Deviation 14.20%
        Tracking Error 0.04%

        This calculation is based on the past 3 years performance information.

        Top Holdings

        Fund Top Holdings as of 21 Nov 2024

        Security Name Weight
        Eli Lilly and Company 8.05%
        UnitedHealth Group Incorporated 7.31%
        Johnson & Johnson 4.97%
        Novo Nordisk A/S Class B 4.35%
        AbbVie Inc. 4.03%
        Merck & Co. Inc. 3.36%
        Abbott Laboratories 2.71%
        Novartis AG 2.71%
        Roche Holding Ltd Dividend Right Cert. 2.65%
        AstraZeneca PLC 2.62%
        Download All Holdings: Download Daily Holdings

        Industry Allocation

        Fund Industry Allocation as of 21 Nov 2024

        Sector Weight
        Pharmaceuticals 40.45%
        Health Care Equipment & Supplies 20.21%
        Health Care Providers & Services 16.27%
        Biotechnology 13.88%
        Life Sciences Tools & Services 8.60%
        Health Care Technology 0.60%

        Geographical Weights

        Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

        Capital Risk: Investing involves risk including the risk of loss of capital.

        Past performance is not a reliable indicator of future performance. 

        First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

        The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSgA and any related financial products.

        Index Change: “Index” reflects linked performance returns of both the MSCI World Health Care 35/20 Capped Index and the MSCI World Health Care Index. The index returns are reflective of the MSCI World Health Care Index from fund inception until November 30, 2020 and of MSCI World Health Care 35/20 Capped Index effective November 30, 2020 to present.

        The recipient is only permitted to view or receive the Index Data in the form in which it is in presented. The recipient understands, acknowledges and agrees that use of the Index Data is at its sole risk. The recipient understands, acknowledges and agrees that the Index Data is provided "as is" and that neither Morningstar UK Limited (Morningstar) nor its content providers warrant the accuracy, completeness, non-infringement, originality, timeliness or any other characteristic of the Index Data. The recipient further understands, acknowledges and agrees that the Index Data is provided to you as an investor in financial products solely pursuant to regulatory requirements and for informational purposes only. The Index Data may not be used by you for commercial purposes and may not be used for trading or other purposes in lieu of a subscription to such Index Data with Morningstar.

        MARKETING COMMUNICATION

        FOR PROFESSIONAL INVESTORS USE ONLY.

         

        SSGA SPDR ETFS MAY NOT BE AVAILABLE OR SUITABLE FOR ALL. SPDR ETFs may be offered and sold only in those jurisdictions where authorised, in compliance with applicable regulations.

         

        Investing involves risk including the risk of loss of principal.

         

        ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

         

        The S&P 500® Index is a product of S&P Dow Jones Indices LLC or its affiliates (“S&P DJI”) and have been licensed for use by State Street Global Advisors.  S&P®, SPDR®, S&P 500®,US 500 and the 500 are trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”) and has been licensed for use by S&P Dow Jones Indices; and these trademarks have been licensed for use by S&P DJI and sublicensed for certain purposes by State Street Global Advisors. The fund is not sponsored, endorsed, sold or promoted by S&P DJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of these indices.

         

        The information provided does not constitute investment advice as such term is defined under the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell any investment. It does not take into account any investor's or potential investor’s particular investment objectives, strategies, tax status, risk appetite or investment horizon. If you require investment advice you should consult your tax and financial or other professional advisor.

         

        The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation. This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.

         

        All information is from SSGA unless otherwise noted and has been obtained from sources believed to be reliable, but its accuracy is not guaranteed.  There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information and it should not be relied on as such.

         

        This content has been issued by State Street Global Advisors Limited (“SSGAL”). Authorized and regulated by the Financial Conduct Authority, Registered   No.2509928. VAT No. 5776591 81. Registered office: 20 Churchill Place, Canary Wharf, London, E14 5HJ. Telephone: 020 3395 6000. Facsimile: 020 3395 6350 Web: www.ssga.com.

         

        FOR EUROPEAN SPDR ETFs and MANAGED FUNDS:

         

        Please refer to the Fund’s latest Key Investor Information Document (KIID) and Prospectus before making any final investment decision. The latest English version of the prospectus and the KIID can be found at www.ssga.com/ch/en_gb/institutional/ic/fund-finder. A summary of investor rights can be found here:

         

        Managed Funds: https://www.ssga.com/library-content/products/fund-docs/summary-of-investor-rights/ssga-investors-rights-summary-non-etf-ireland.pdf

         

        SPDR ETFs: https://www.ssga.com/library-content/products/fund-docs/summary-of-investor-rights/ssga-spdr-investors-rights-summary.pdf

         

        Note that the Management Company may decide to terminate the arrangements made for marketing and proceed with de-notification in compliance with Article 93a of Directive 2009/65/EC.

         

        SPDR ETFs is the exchange traded funds ("ETF") platform of State Street Global Advisors and is comprised of funds that have been authorised by Central Bank of Ireland as open-ended UCITS investment companies.

         

        SSGA SPDR ETFs Europe I & SPDR ETFs Europe II plc issue SPDR ETFs, and is an open-ended investment company with variable capital having segregated liability between its sub-funds. The Company is organized as an Undertaking for Collective Investments in Transferable Securities (UCITS) under the laws of Ireland and authorized as a UCITS by the Central Bank of Ireland.


        Managed Pension Funds:

        Investing in the Managed Pension Fund is effected by means of an insurance policy written by Managed Pension Funds Limited, a member of the State Street group of companies. This document should not be construed as an invitation or inducement to engage in investment activity. The Managed Pension Fund is available to pension schemes (including overseas schemes) registered with HM Revenue and Customs for the purposes of Chapter 2 of Part IV of the Finance Act 2004. This document should therefore only be circulated to the Trustees of such schemes and their advisers who are deemed to be professional persons (this includes professional clients and eligible counterparties as defined by the Financial Conduct Authority). It should not be circulated to or relied upon by any other persons. In particular scheme members should consult with their employer or scheme trustee. Please note that neither State Street Global Advisors Limited or Managed Pension Funds Limited offer actuarial services and any investment service undertaken by those firms with an objective of matching projected pension fund liabilities does not include, or take responsibility for, the calculation of projected liabilities. Any illustrations exclude the impact of fees, and actual investment returns may differ from projected cashflows, these projected cashflows are not projections of any future benefit payable under a specific policy.

         

        We recommend you read the MPF Key Features Document and Policy Document for full details about the Fund, including fees and risks. Please refer to the “General Risks Applicable to All Sub-Funds” and to the relevant “Sub-Fund Specific Risk Factors” sections of the “Key Features of Managed Pension Funds Limited” document, which is available at: https://www.ssga.com/publications/firm/Key-Features-of-Managed-Pension-Funds-Limited.pdf

         

        FOR STRATEGIES:

         

        This document provides summary information regarding the Strategy. This document should be read in conjunction with the Strategy's Disclosure Document, which is available from SSGA. The Strategy Disclosure Document contains important information about the Strategy, including a description of a number of risks.
         

        US SPDR ETFs

         

        NOTICE TO PERSONS IN THE EUROPEAN ECONOMIC AREA ("EEA")

         

        The Certain US Domiciled funds mentioned on the website is permitted to market into the relevant EEA jurisdiction with UK audience pursuant to either Article 42 of AIFMD (if and as implemented under national laws of such member state); or (ii) can otherwise be lawfully offered or sold (including on the basis of an unsolicited request from a professional client/qualified investor).

         

        The Certain US Domiciled funds mentioned on the website is an alternative investment fund for the purpose of the European Union Alternative Investment Fund Managers Directive (Directive 2011/61/EU) (the “AIFMD”). It is not a regulated collective investment scheme for purposes of the Financial Services and Markets Act 2000 of the United Kingdom (“FSMA”). The promotion of these Certain US Domiciled funds and the distribution of this material in the UK is restricted by law to Professional Investors Only.

         

        These Certain US Domiciled funds provided on the website is an alternative investment funds for the purpose of the European Union Alternative Investment Fund Managers Directive (Directive 2011/61/EU) ("AIFMD"). SSGA Funds Management, Inc. or State Street Global Advisors Trust Company (excluding SPDR® Gold Trust (“GLD®”) and SPDR® Gold MiniShares® Trust (“GLDM®”) is the alternative investment fund manager ("AIFM") of the fund.

         

        SSGA Funds Management, Inc. serves as the investment advisor to the SPDR ETFs that are registered with the United States Securities and Exchange Commission under the Investment Company Act of 1940. SSGA Funds Management, Inc. is an affiliate of State Street Global Advisors Limited.

         

        Before investing, consider the funds’ investment objectives, risks, charges and expenses. To obtain a prospectus which contains this and other information, visit ssga.com or talk to your financial advisor. Read it carefully before investing.

         

        The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without SSGA’s express written consent.

        4978691.4.1.EMEA.INST

        Exp: 30.06.2025

        © [[]] %%State Street Corporation%%. All rights reserved.